FDA Warning Letter — BP

Case 560696 — FEI 3013182312

The FDA took a Warning Letter action against BP on Jul 26, 2018 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Jul 26, 2018
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.